You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
紅日藥業(300026.SZ)擬將2019年度審計機構變更為信永中和
格隆匯 12-25 21:34

格隆匯12月25日丨紅日藥業(300026.SZ)公佈,公司於2019年12月25日召開了第七屆董事會第四次會議、第七屆監事會第四次會議,審議通過了《關於變更會計師事務所的議案》,該議案尚需提請公司2020年第一次臨時股東大會審議。

公司原聘請的審計機構為瑞華會計師事務所(特殊普通合夥)(“瑞華事務所”)在執業過程中堅持獨立審計原則,客觀、公正、公允地反映公司財務狀況,切實履行了審計機構應盡的職責,從專業角度維護了公司及股東的合法權益。鑑於瑞華事務所已連續多年為公司提供審計服務,為保證公司的審計獨立性,同時根據公司戰略發展需要,經雙方事前溝通和協商,瑞華事務所不再擔任公司審計機構。

經公司審慎研究,以及董事會審計委員會提議擬將2019年度審計機構變更為信永中和會計師事務所(特殊普通合夥)(“信永中和事務所”),瑞華事務所對公司變更會計師事務所的事項無陳述意見,公司董事會對瑞華事務所多年來的辛勤工作表示衷心感謝。

公司於20191225日召開了第七屆董事會第次會議、第七屆監事會第次會議審議通過了《關於變更會計師事務所的議案》,同意聘請信永中和事務所為公司2019年度的審計機構聘期一年。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account